In the quest to outshine the broader market, stock pickers diligently seek out stocks with the potential for superior performance. Making the right choices can significantly elevate your wealth.
After finishing at $67.29 in the prior trading day, CVS Health Corp (NYSE: CVS) closed at $65.17, down -3.15%. In other words, the price has decreased by -$3.15 from its previous closing price. On the day, 9.7 million shares were traded. CVS stock price reached its highest trading level at $67.445 during the session, while it also had its lowest trading level at $64.45.
Ratios:
Our goal is to gain a better understanding of CVS by taking a closer look at its different ratios. It provided that stocks Price–to–Cash (P/C) ratio for the trailing twelve months (TTM) is standing at 7.42 whereas its Price-to-Free Cash Flow (P/FCF) for the term is 13.00. For the most recent quarter (mrq), Quick Ratio is recorded 0.60 and its Current Ratio is at 0.81. In the meantime, Its Debt-to-Equity ratio is 1.10 whereas as Long-Term Debt/Eq ratio is at 1.00.
Upgrades & Downgrades
In addition, analysts’ ratings and any changes thereto give investors an idea of the stock’s future direction. In the most recent recommendation for the company, Leerink Partners on February 13, 2025, Upgraded its rating to Outperform and sets its target price to $75 from $55 previously.
Insider Transactions:
The insider trade also gives investors a glimpse into the future direction of stock prices, which can be beneficial to investors. A recent insider transaction in this stock occurred on Mar 05 ’25 when Clark James David sold 7,513 shares for $66.35 per share. The transaction valued at 498,488 led to the insider holds 8,394 shares of the business.
Clark James David bought 7,513 shares of CVS for $498,489 on Mar 05 ’25. On Feb 18 ’25, another insider, Mahoney Michael F, who serves as the Director of the company, bought 30,000 shares for $66.70 each. As a result, the insider paid 2,001,000 and bolstered with 39,356 shares of the company.
Valuation Measures:
Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, CVS now has a Market Capitalization of 84945829888 and an Enterprise Value of 154263011328. As of this moment, CVS’s Price-to-Earnings (P/E) ratio for their current fiscal year is 17.82, and their Forward P/E ratio for the next fiscal year is 9.46. The expected Price-to-Earnings-to-Growth (PEG) calculation for the next 5 years is 1.32. For the stock, the TTM Price-to-Sale (P/S) ratio is 0.22 while its Price-to-Book (P/B) ratio in mrq is 1.09. Its current Enterprise Value per Revenue stands at 0.416 whereas that against EBITDA is 12.228.
Stock Price History:
The Beta on a monthly basis for CVS is 0.59, which has changed by -0.04861313 over the last 52 weeks, in comparison to a change of 0.017286062 over the same period for the S&P500. Over the past 52 weeks, CVS has reached a high of $71.45, while it has fallen to a 52-week low of $43.56. The 50-Day Moving Average of the stock is -0.69%, while the 200-Day Moving Average is calculated to be 10.97%.
Shares Statistics:
The stock has traded on average 10.86M shares per day over the past 3-months and 13971200 shares per day over the last 10 days, according to various share statistics. A total of 1.26B shares are outstanding, with a floating share count of 1.26B. Insiders hold about 0.14% of the company’s shares, while institutions hold 84.42% stake in the company. Shares short for CVS as of 1743379200 were 18256861 with a Short Ratio of 1.68, compared to 1740700800 on 20554799. Therefore, it implies a Short% of Shares Outstanding of 18256861 and a Short% of Float of 1.46.
Dividends & Splits
In the trailing 12 months, CVS’s forward annual dividend rate was 2.66, compared to 2.66 this year. Against a Trailing Annual Dividend Yield of 0.039530393The stock’s 5-year Average Dividend Yield is 3.09. The current Payout Ratio is 72.76% for CVS, which recently paid a dividend on 2025-01-23 with an ex-dividend date of 1745280000. Stock splits for the company last occurred on 2005-06-07 when the company split stock in a 2:1 ratio.
